Sign In
Buy EVH
$3.78
-0.180 (-4.55%)
At Close: Jun 03, 2026
Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results
04:10pm, Tuesday, 24'th Feb 2026
WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions throug
Evolent Health (NYSE:EVH) Share Price Crosses Below Fifty Day Moving Average – Should You Sell?
01:42am, Tuesday, 17'th Feb 2026
Shares of Evolent Health, Inc (NYSE: EVH - Get Free Report) crossed below its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $3.69 and traded as low as $2.62.
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
11:02am, Wednesday, 04'th Feb 2026
WASHINGTON, Feb. 4, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its
Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of “Moderate Buy” by Analysts
02:34am, Monday, 05'th Jan 2026
Shares of Evolent Health, Inc (NYSE: EVH - Get Free Report) have earned an average recommendation of "Moderate Buy" from the sixteen ratings firms that are presently covering the firm, Marketbeat.com
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
04:15pm, Friday, 02'nd Jan 2026
WASHINGTON, Jan. 2, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through
Is the Options Market Predicting a Spike in Evolent Health Stock?
09:51am, Tuesday, 23'rd Dec 2025
Investors need to pay close attention to EVH stock based on the movements in the options market lately.
Evolent Health, Inc. (EVH) Presents at UBS Global Healthcare Conference 2025 Transcript
10:21pm, Tuesday, 11'th Nov 2025
Evolent Health, Inc. ( EVH ) UBS Global Healthcare Conference 2025 November 11, 2025 5:00 PM EST Company Participants John Johnson - Chief Financial Officer Conference Call Participants Kevin Caliendo
Evolent Health, Inc. (EVH) Q3 2025 Earnings Call Transcript
02:46pm, Friday, 07'th Nov 2025
Evolent Health, Inc. ( EVH ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Seth Blackley - Co-Founder, CEO & Director John Johnson - Chief Financial Officer Conference Call P
Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics
09:31pm, Thursday, 06'th Nov 2025
The headline numbers for Evolent Health (EVH) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Stree
Evolent Health (EVH) Misses Q3 Earnings Estimates
07:36pm, Thursday, 06'th Nov 2025
Evolent Health (EVH) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.04 per share a year ago.
WASHINGTON , Nov. 6, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AO
Evolent Announces Third Quarter 2025 Results
04:10pm, Thursday, 06'th Nov 2025
Q3 2025 financial results ahead of expectations. Announces more than $500 million in newly-contracted annualized revenue to launch in 2026.
Evolent To Release Third Quarter 2025 Financial Results on Thursday, November 6, 2025
08:30am, Thursday, 09'th Oct 2025
Company to Participate in Upcoming Conferences WASHINGTON , Oct. 9, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex
Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners
04:10pm, Tuesday, 23'rd Sep 2025
Transaction enhances focus on specialty condition management and accelerates Evolent's deleveraging path. Proceeds from the transaction to be used to prepay senior term debt; Immediately accretive to
CVS vs. EVH: Which Value-Based Care Stock Deserves Investor Attention?
01:16pm, Wednesday, 17'th Sep 2025
CVS shows revenue growth and raised guidance, while EVH faces revenue declines but pursues oncology deals and efficiency gains.
